NeuroVive Pharmaceutical AB FCF yield
What is the FCF yield of NeuroVive Pharmaceutical AB?
The FCF yield of NeuroVive Pharmaceutical AB is -456.11%
What is the definition of FCF yield?
Free cash flow yield (FCF yield) is a financial ratio that compares the free cash flow per share to the market value per share. The ratio is calculated by dividing free cash flow per share by the current share price.
ttm (trailing twelve months)
Free cash flow yield is a good measure of the company’s cash flow in respect to the company’s size. Larger companies tend to have a higher cash flow yield, but it’s not always the case. The higher the free cash flow yield, the more cash the company is generating that can be quickly accessed to satisfy its obligations. The lower the free cash flow yield, the more money investors are putting into the company with little result. The higher the ratio, the more attractive the investment is as it suggests that investors are paying less for each unit of free cash flow.
Free cash flow acts as an indicator of how capable a company is of repaying all of its obligations. It is a solid indicator of how financially stable a company is. It is calculated as:
Free cash flow yield = Free cash flow per share / market price per share
FCF yield of companies in the Health Care sector on OTC compared to NeuroVive Pharmaceutical AB
What does NeuroVive Pharmaceutical AB do?
Abliva AB (publ), a pharmaceutical company, engages in the research and development of mitochondrial medicine. The company is developing KL1333 that is in Phase I clinical trials for the chronic treatment of primary mitochondrial diseases; NV354, which is in the preparation for clinical trials for the treatment of primary mitochondrial diseases with Complex I deficiency; and NeuroSTAT for traumatic brain injury. It has collaboration agreements with Isomerase, Yungjin Pharm, University of Pennsylvania, Children's Hospital of Philadelphia, Patheon, and Oroboros Instruments. The company was formerly known as NeuroVive Pharmaceutical AB (publ) and changed its name to Abliva AB (publ) in May 2020. Abliva AB (publ) was incorporated in 2000 and is headquartered in Lund, Sweden.
Companies with fcf yield similar to NeuroVive Pharmaceutical AB
- EVIO has FCF yield of -476.77%
- Shift Technologies has FCF yield of -471.17%
- Redhill Biopharma has FCF yield of -469.50%
- Spring Bank Pharmaceuticals has FCF yield of -466.79%
- Jinshang Bank Co has FCF yield of -456.80%
- Metro Bank Plc has FCF yield of -456.35%
- NeuroVive Pharmaceutical AB has FCF yield of -456.11%
- Aeglea BioTherapeutics Inc has FCF yield of -455.63%
- Evofem Biosciences Inc has FCF yield of -451.94%
- Nabriva Therapeutics Plc has FCF yield of -450.47%
- China XD Plastics Co Ltd has FCF yield of -450.12%
- Amicus Therapeutics has FCF yield of -441.27%
- Clearford Water Systems has FCF yield of -440.49%